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The purpose of this review is to try to take
a practical approach toward the management of patients with renal calculous disease. This will be a
personal approach; I will, however, try to avoid
injecting my prejudices and research interests. I
want to show that proper management can be
achieved even in the most unsophisticated environment.
Clinical Evaluation. It is often true that the
first evaluation is the most important in giving a
clue to underlying cause. Therefore, every effort
must be made to avoid failure and thus discourage
both clinician and patient. Patients with renal stones
generally seek help when they are experiencing
symptoms which may be due to partial obstruction
with loss of appetite and perhaps partial dehydration. This is not the time to investigate one's patient as the underlying metabolic disorder may be
completely obscured. Thus, delay until the patient
has resumed his normal state is important.
I do not believe that it is worthwhile in this
area to submit a patient to an evaluation who has
passed and/or made a single stone. We live in a
stone belt. In this area, 80% of the patients who
have made only one stone will not make another.
In the remaining percentage of patients who have
made one stone, there is nearly an 80% chance that
they will make another within a year. As yet we
have no test available to us that will allow us to
distinguish the true stone former.
A careful history must probe for previm.is episodes and associated conditions such as urinary infections, excessive dehydration, diarrhea, fractures
with prolonged immobilization, high alkali, Vitamin
D or milk intake. Certain drugs, for example
Diamox® and steroids, are associated with stone
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formation. A family history of calculi is often present
and may be so prominent, as in cystinuria or oxaluria,
that the patient already knows the diagnosis.
A careful urinalysis with recording of the pH,
crystal content, and presence of bacteria is still the
best single test in the management of these patients.
The following · laboratory evaluations are important and can be done while in the hospital or as
an out-patient:
1) Urine for culture and sensitivity.
2) Urine for cyanide-nitroprusside test (screening for cystine).
3) Teach the patient to test the pH of every
voided specimen of urine with nitrazine
paper (Lilly Company).
4) Three determinations of serum calcium,
phosphorus, uric acid, and creatinine and
additional routine determinations of total
protein, albumin, alkaline phosphatase, and
·
electrolytes.
5) Three ·24-hour urines for calcium, phosphorus, magnesium, uric acid, and creatinine.
6) Analysis of stones should include x-ray
diffraction or crystallographic analysis which
is readily available. This is very important
because, at this time, medical management
is directed toward the crystalline components.
7) Plain film of the abdomen with an intravenous pyelogram. The roentgenographic
appearance of calculi with particular attention to the position in the parenchyma
or collecting system and also evidence of
layering of calcium over a possibly radiolucent nidus are most important in arriving
at the diagnosis for a specific cause of a
stone and thus planning the therapy. It
goes without saying that it is necessary to
exclude all forms of obstruction, and atMCV QUARTERLY 9(3): 212-215, 1973
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tention should be paid to whether there is
parenchymal calcification which can take
various forms . A peppering of small calculi
outlining the renal papilla often suggests
renal tubular acidosis; however, if this is
confined to only one papilla then one would
think more of a medullary sponge kidney.
If there is evidence of infection of the
urinary tract, then I believe that a voiding
cystourethrogram should always be carried
out to detect the presence of vesicoureteral
reflux.
Calculi.
Uric Acid Calculi. In this area, uric acid
calculi make up 15% of all calculi seen. They are
the only truly radiolucent stones and are not necessarily associated with hyperuricemia and hyperuricosuria. They are most often associated with
excretion of unusually acid urine and repeated bouts
of dehydration. One may see these types of stones
in patients with chronic diarrhea. Certain cytotoxic
drugs, particularly those used in the treatment of
lymphomas and leukemia, the thiazides, salicylates,
and steroids will cause uricosuria, and in the presence of low urinary pH, uric acid stones can form.
Patients will respond very rapidly to a program
of high urinary output and alkalization. The patient
must continually check his urine, particularly the
morning specimen, and adjust the dosage of bicarbonate so that the pH is above 6.0.
In some patients it may be necessary to add
allopurinol to the regimen, and the dosage will vary
from 100-800 mg daily. This potent enzyme inhibitor will prevent further uric acid calculi formation, but there is the theoretical possibility of
xanthine stone formation so alkalization must be
continued to prevent this possibility.
At present, it is possible to completely prevent
uric acid calculi. Surgery should play a minimal
part in the management of these patients even when
stones are present in the urinary tract. It has long
been known that high output of alkaline urine will
sometimes dissolve these stones. The introduction
of allopurinol to the armamentarium has provided
some dramatic cures. I have five patients in whom
uric acid staghorns have completely dissappeared
after an average of six months.
Cystine Calculi. The diagnosis of this familial
disease will usually follow from the routine testing
noted above and the finding of hexagonal crystals
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in acid urine. One should stress again that these
stones are radio-opaque because of their 27% content of sulphur and that they have a typical ground
glass appearance.
At the Medical College of Virginia, we have
an unusually high incidence of cystine stones because of the presence of this inherited metabolic
disease in the Chickahominy Indians. Usually, the
incidence is only 0.5-1 % of all stones.
Therapy is directed toward maintaining the
urinary volume in excess of 2,500 ml per day, including an intake of at least 500 ml of fluids in the
mid-sleep hours. The urine is, maintained alkaline,
and the patient is instructed to check his urine and
adjust the dosage of his alkalizing medication in
order to keep the pH of the urine above 6.5. If the
patient follows such a regimen conscientiously, the
solubility of cystine in urine will increase and further
stone formation may not occur. This can readily be
checked by routine urinalysis. Patients who are unsuccessful in such therapy may require the addition
of n-penicillamine to the treatment program. This
drug is given in dosages of 1-4 g per day guided
by the screening tests for cystine (nitroprusside
tests).
n-Penicillamine is not completely without its
complications; a rash may occur but can be abated
by stopping the medication for two weeks and then
resuming it by gradually increasing it from 250 mg
per day to the required daily dose. Nephrotic syndrome has occurred and requires cessation of the
therapy along with prolonged medical observation.
There is an increasing number of reports of patients
losing their sense of taste while on this drug.
Reappearance of the stones or failure of the
stones to dissolve might imply failure of therapy.
On several occasions, however, we have found that
this was due to the production of stones of other
chemical makeup; therefore, these patients must be
very carefully followed and watched in case such an
event occurs.
It is extremely important when treating these
patients with penicillamine to keep the dose as low
as possible, that is, to keep the urinary cystine level
below 250 mg per day by the minimum dose of
o-penicillamine possible. It is conceivable, and we
have seen it here on two occasions, that prolonged
high doses of penicillamine will interfere with collagen maturation and thus give rise to bruising and
striae formation; great care must be exercised in the
management of these patients.
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Calcium Calculi. The stones that contain calcium are found in a wide spectrum of conditions
that can be broken down into individual management
problems once the proper diagnosis has been made.
The principal breakdown is into those patients with
or without infection. One should not lose sight of
the fact that many so-called infectious stones may
have had as a nucleus an uninfected stone so one
should adjust the therapeutic attack accordingly.
Triple Phosphate Calculi. Stones associated
with infection imply the presence of stones containing
varying amounts of calcium magnesium ammonium
phosphate. Their roentgen appearance is variable as
they may have a high content of so-called matrix.
Therapy is directed toward eliminating the infection.
It is essential to correct obstruction, diabetes and
hyperparathyroidism, and to remove all foreign bodies; otherwise, any therapy directed toward the infection will be doomed to failure.
Appropriate antibiotic therapy must be intensive
and often prolonged until the urine is sterile and
stays that way. Acidification of the urine is certainly
very helpful. A regimen using methenamine and
ascorbic acid is helpful. We have found that in some
patients methylene blue will lower the urinary pH,
and it seems to prevent organization of the matrix
and prevents it from binding the calcium ions.
Oral use of magnesium or phosphates is contraindicated. If one can lower the urinary phosphorus
by use of a low phosphorus-containing diet and
Basaljel®, then success has been achieved. It is often
extremely difficult to insure that patients remain on
this regimen, however, and I no longer use it except
with very compulsive patients.
I believe it can rarely be said that a stone is
purely secondary to infection.
Calcium Oxalate and Calcium Phosphate. Prior
to discussion of the management of these common
stones, a few general observations should be made.
Pure calcium phosphate stones are most commonly
found in association with metabolic diseases; for
example, hyperparathyroidism, renal tubular acidosis,
immobilization syndrome, and stones associated with
the hypercalcemia of malignant disease and sarcoidosis; a more intensive investigation by a metabolic unit is indicated. Many patients will alternate
calcium oxalate and phosphate stones, presumably
due to the variation in urinary pH, as calcium phosphate precipitates at high urinary pH. Hyperoxaluria
should be suspected in children or young patients
with recurrent stone formation.
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Calcium oxalate and/ or phosphate calculi represent a disease complex which has many factors associated with it, and therefore, it seems that one
should direct attention and therapy toward the most
prominent biochemical abnormality that the preliminary investigation turns up; always remember
that continuous monitoring and flexibility are essential.
Hypercalciuria. There is still considerable
controversy as to the best therapy for this common
problem. The following therapies are recommended:
Thiazides. If given in a dosage of 500 mg twice
daily, they will reduce the urinary calcium and elevate the magnesium. There are certain side effects,
however, which may be potentially harmful. Metabolic acidosis and potassium deficiency have been
reported. Citrate excretion is practically abolished
and hyperuricemia may occur. Rarely, this will cause
hypercalcemia unmasking that group of people who
exhibit normocalcemic hyperparathyroidism. All of
these patients must be warned to keep their sodium
intake low, or the effect of the thiazides will be nullified . It is questionable whether this form of therapy
should be combined with the phosphate type as there
exists the potential of exacerbating the renal damage
that can occur from phosphate ingestion.
Neutral Orthophosphate. In 1958 and 1959,
Drs. Howard and Thomas made a crucial observation concerning "evil urine" and its ability to calcify
rachitic rat cartilage while good urine would not
do this. This led to the discovery that neutral orthophosphate taken orally will consistently lower urinary
calcium and convert evil to good urine. Subsequent
work by others in the field has confirmed that a
dosage of 1.3-1.5 g per day is sufficient to stop stone
formation. Unfortunately, this dosage is sometimes
limited by the diarrhea which may occur.
Uricosuria. There is a group of patients whose
only detectable metabolic abnormality was a relative
uricemia and uricosuria. Interestingly, these patients
often belong to the so-called "young executive stone
former." It has been possible to control their oxalate
stone formation with a low dosage of allopurinol
(50 mg) and alkalization.
Calcium/Magnesium Ratio. There is a group
of stone formers who have a ratio of these ions to
each other greater than three and who appear to
benefit from magnesium oxide therapy usually administered as Milk of Magnesia® tablets. I should
stress that some workers have not been able to
demonstrate these differences so that if one uses
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this therapy, very careful monitoring and study is
essential.
Lack of Detectable Abnormality. There is a
group of people in whom there is no detectable abnormality on the biochemical survey. A variety of
therapeutic approaches is currently under study.
Dr. Prien is presently conducting a study on
the effect of magnesium oxide (300 mg per day)
and pyridoxine (10 mg per day) in the.management
of recurrent stone formers. He will provide the
protocol and therapy in return for follow-up results.
Studies on methylene blue by Boyce and by
Smith have been reported previously. At this time,
methylene blue ( 65 mg three times a day) would
seem to be effective in preventing the formation of
stones in uninfected calcium oxalate stone formers.
I admit that it may also be helpful in "urine watchers" in that they will tend to keep up an adequate
fluid intake.
Discredited Therapy. Aspirin, hyaluronidases,
and cranberry juice have fallen into disrepute as
forms of therapy.
General Measures. As has been indicated, each
patient will require individualized therapy. It is extremely important to be prepared to evaluate patients
continually as to their response to a particular
therapy and, if necessary, to shift to another.
Dietary therapy is not emphasized; however, all
patients are instructed in a simple low calcium diet.
There are a few people who can remain on diets
and successfully reduce the urinary calcium levels.
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All patients are taught to measure their urine volume and to aim to maintain an output above 100
ml in one hour. It is probably wise to advise patients
to avoid excessive consumption of soft drinks, since
a carbohydrate load has been shown to induce hypercalciuria of frightening proportions. I believe the
intelligent participation by a patient in his medical
management is probably the single most important
facet in the management of recurrent urinary calculi.
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